Keith Pratz, MD, Assistant Professor of Oncology, Sidney Kimmel, Comprehensive Cancer Center, Johns Hopkins University, Discusses Phase I Study Of Gilteritinib. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Advertisement